132 related articles for article (PubMed ID: 1416908)
21. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice.
Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL
J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998
[TBL] [Abstract][Full Text] [Related]
22. Murine leukaemia virus p30 heterogeneity as revealed by two-dimensional gel electrophoresis is not an artefact of the technique.
Katoh I; Yoshinaka Y; Luftig RB
J Gen Virol; 1984 Apr; 65 ( Pt 4)():733-41. PubMed ID: 6323621
[TBL] [Abstract][Full Text] [Related]
23. Double infection of BALB/c mice with Rauscher murine leukemia and Herpes simplex virus type 2.
Oleszak E; Inglot AD
Arch Immunol Ther Exp (Warsz); 1980; 28(2):337-44. PubMed ID: 6255890
[TBL] [Abstract][Full Text] [Related]
24. Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model.
Chirigos MA; Ussery MA; Rankin JT; Herrmann D; Bicker U; Black PL
Immunopharmacol Immunotoxicol; 1990; 12(1):1-21. PubMed ID: 1693633
[No Abstract] [Full Text] [Related]
25. Different lymphoid cell targets by transformation by replication-competent Moloney and Rauscher mouse leukemia viruses.
Reddy EP; Dunn CY; Aaronson SA
Cell; 1980 Mar; 19(3):663-9. PubMed ID: 6767548
[TBL] [Abstract][Full Text] [Related]
26. Antiviral effect of haloperidol on Rauscher murine leukemia virus.
Wunderlich V; Fey F; Sydow G
Arch Geschwulstforsch; 1980; 50(8):758-62. PubMed ID: 7224819
[TBL] [Abstract][Full Text] [Related]
27. Inhibition by tuftsin of Rauscher virus leukemia development in mice.
Knyszynski A; Gottlieb P; Fridkin M
J Natl Cancer Inst; 1983 Jul; 71(1):87-90. PubMed ID: 6575215
[TBL] [Abstract][Full Text] [Related]
28. Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice.
Ihle JN; Denny TP; Bolognesi DP
J Virol; 1976 Mar; 17(3):727-36. PubMed ID: 56459
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic activity of narcissus alkaloid on Rauscher leukemia and comparison with standard drugs.
Furusawa E; Furusawa S; Morimoto S; Cutting W
Proc Soc Exp Biol Med; 1971 Apr; 136(4):1168-73. PubMed ID: 5554461
[No Abstract] [Full Text] [Related]
30. In vitro and in vivo enhancement of ddI activity against Rauscher murine leukemia virus by ribavirin.
Allen LB; Quenelle DC; Westbrook L; Taylor BA; Prichard MN; Brazier AD; Hollingshead MG; Shannon WM
Antiviral Res; 1995 Jun; 27(3):317-23. PubMed ID: 8540752
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27.
Lutz H; Pedersen NC; Durbin R; Theilen GH
J Immunol Methods; 1983 Jan; 56(2):209-20. PubMed ID: 6186744
[TBL] [Abstract][Full Text] [Related]
32. Enzyme-linked immunosorbent assay for detection of retroviral gp70 and gp70-anti-gp70 immune complexes in sera from SLE mice.
Izui S; Lange G
Clin Exp Immunol; 1988 Jan; 71(1):45-9. PubMed ID: 3349648
[TBL] [Abstract][Full Text] [Related]
33. Viral genes involved in leukemogenesis. I. Generation of recombinants between oncogenic and nononcogenic mouse type-C viruses in tissue culture.
Aaronson SA; Barbacid M
J Exp Med; 1980 Feb; 151(2):467-80. PubMed ID: 6153214
[TBL] [Abstract][Full Text] [Related]
34. Alteration of the syncytium-forming property of XC cells by productive Moloney leukemia virus infection.
Cham JC; Vera N; Allen PT; East JL; Knesek JE
Cancer Res; 1975 Jul; 35(7):1854-7. PubMed ID: 1169118
[TBL] [Abstract][Full Text] [Related]
35. Immune reactivity of RBL-3, a nonproducer leukemia induced by Rauscher murine leukemia virus in C57BL/6 mice.
Chang KS
J Natl Cancer Inst; 1978 Jul; 61(1):107-12. PubMed ID: 276620
[TBL] [Abstract][Full Text] [Related]
36. In situ ELISA for the evaluation of antiviral compounds effective against human cytomegalovirus.
Tatarowicz WA; Lurain NS; Thompson KD
J Virol Methods; 1991; 35(2):207-15. PubMed ID: 1667788
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein.
Rein A; Ott DE; Mirro J; Arthur LO; Rice W; Henderson LE
J Virol; 1996 Aug; 70(8):4966-72. PubMed ID: 8764002
[TBL] [Abstract][Full Text] [Related]
38. Rescue and transmission of a replication-defective variant of moloney murine leukemia virus.
Rein A; Benjers BM; Gerwin BI; Bassin RH; Slocum DR
J Virol; 1979 Feb; 29(2):494-500. PubMed ID: 219244
[TBL] [Abstract][Full Text] [Related]
39. Properties of RBL-5 leukemia cells cultivated in vitro.
Liu WT; Rogers MJ; Law LL; Chang KS
J Natl Cancer Inst; 1977 Jun; 58(6):1661-4. PubMed ID: 864745
[TBL] [Abstract][Full Text] [Related]
40. Binding characteristics of Rauscher leukemia virus envelope glycoprotein gp71 to murine lymphoid cells.
Fowler AK; Twardzik DR; Reed CD; Weislow OS; Hellman A
J Virol; 1977 Dec; 24(3):729-35. PubMed ID: 563478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
